Publications by authors named "Lan-hu Hao"

Article Synopsis
  • The study examined how well rifampicin (RFP) from different fixed-dose combination (FDC) drugs is absorbed compared to a reference drug in healthy volunteers.
  • The research involved 18 to 20 male participants and utilized open-label, randomized crossover designs for testing various FDC formulations.
  • Results indicated that while concentrations of RFP in some formulations were acceptable, only one formulation (A) matched the bioavailability of the reference product, with the others showing lower effectiveness.
View Article and Find Full Text PDF

A series of novel N-phenylbenzamide derivatives were synthesized and their anti-EV 71 activities were assayed in vitro. Among the compounds tested, 3-amino-N-(4-bromophenyl)-4-methoxybenzamide (1e) was active against the EV 71 strains tested at low micromolar concentrations, with IC50 values ranging from 5.7 ± 0.

View Article and Find Full Text PDF

The influenza virus is a persistent cause of mortality and morbidity on an annual basis and thus presents itself as an important target for pharmaceutical investigation. In this work, substituted bisaryl amide compounds were found to be a new class of potential anti-influenza agents, and a series of substituted bisaryl amide compounds were synthesised and evaluated for their anti-influenza virus activities. The analysis of the results produced a preliminary structure-activity relationship study (SAR).

View Article and Find Full Text PDF

Unlabelled: Host cellular factor apolipoprotein B messenger RNA (mRNA)-editing enzyme catalytic polypeptide-like 3G (hA3G) is a cytidine deaminase that inhibits a group of viruses including human immunodeficiency virus-1 (HIV-1). In the continuation of our research on hA3G, we found that hA3G stabilizing compounds significantly inhibited hepatitis C virus (HCV) replication. Therefore, this study investigated the role of hA3G in HCV replication.

View Article and Find Full Text PDF